2001
Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France
Moatti J, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France. European Addiction Research 2001, 7: 40-45. PMID: 11316925, DOI: 10.1159/000050713.Peer-Reviewed Original ResearchConceptsInjection drug usersNeedle exchange programsSterile syringesNEP usersNew syringesPharmacy salesCharacteristics of IDUsDrug usersPrevention of HIVDrug use characteristicsHIV prevention programsSelf-administered questionnaireMethadone programsHeroin injectorsUseful adjunctPrevention programsInfectious diseasesProgram utilizationHIVSyringesPharmacyExchange programsQuestionnaireBuprenorphineDiseaseInjecting misuse of buprenorphine among French drug users
Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J. Injecting misuse of buprenorphine among French drug users. Addiction 2001, 96: 267-272. PMID: 11182872, DOI: 10.1046/j.1360-0443.2001.96226710.x.Peer-Reviewed Original ResearchConceptsDrug maintenance treatmentSample of IDUsNeedle exchange programsDrug usersMisuse of buprenorphineCross-sectional surveySelf-administered questionnaireAmbulatory prescriptionsMaintenance treatmentAmbulatory careCommunity pharmaciesBuprenorphineSterile syringesSubstantial riskIDUsLatter groupIllicit usePolydrug usersHIVExchange programsMonthsRisky behaviorsPrescriptionPharmacyMisuse
2000
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART
Carrieri M, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y, Group T. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. Drug And Alcohol Dependence 2000, 60: 51-54. PMID: 10821989, DOI: 10.1016/s0376-8716(00)80007-1.Peer-Reviewed Original ResearchConceptsEfficacy of HAARTDrug usersBuprenorphine substitution treatmentViral load trendsActive antiretroviral therapyFrench cohort studyHIV viral loadUse of buprenorphineInjection drug usersVirologic responseAntiretroviral therapyCohort studyBuprenorphine treatmentTreatment initiationViral loadMaintenance treatmentPotential confoundersHAARTSubstitution treatmentBuprenorphineHIVIndividual treatmentPatientsTreatmentLinear regression models